Dimethyl Fumarate in Adrenomyeloneuropathy

NCT06513533 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

40

Enrollment

INDIV

Sponsor class

Conditions

Adrenomyeloneuropathy Without Cerebral Involvement

Interventions

OTHER: Placebo
DRUG: Dimethyl fumarate

Sponsor

Pujol, Aurora, M.D.

Collaborators

[object Object]
[object Object]
[object Object]